Danaher Corporation is a global science and technology company that designs, manufactures, and markets a diverse range of industrial and healthcare products and solutions
The company's operations are organized into several segments, including life sciences, diagnostics, dental, and environmental and applied solutions. Danaher focuses on advancing vital sciences and technologies through innovative products and services that enhance the quality of life. With a commitment to customer satisfaction, the company leverages its extensive expertise in engineering and manufacturing to deliver reliable and efficient solutions across various industries, helping to drive improved outcomes in healthcare, environmental monitoring, and industrial processes.
Aldevron, a global leader in the production of DNA, RNA and protein, has launched its latest innovation, Alchemy™ cell-free DNA technology. This revolutionary technology represents a significant advancement in synthetic DNA manufacturing, offering a cell-free, enzymatic process to generate linear DNA (linDNA) templates for in vitro transcription (IVT) synthesis of mRNA molecules.
CAMBRIDGE, Mass. and BREA, Calif. and TOKYO, July 30, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB), Beckman Coulter, Inc. and Fujirebio announced a collaboration to potentially identify and develop blood-based biomarkers for tau pathology in the brain and to potentially clinically advance and potentially commercialize new tests for tau pathology in Alzheimer’s disease (AD). The development of tau-specific blood-based biomarkers that can measure a patient’s tau burden could provide critical insights into the underlying pathological processes of AD and may help advance the development of a new generation of therapies impacting tau pathology.
Danaher Corporation (NYSEDHR) has caught the attention of the investment community today with its bullish price action. The company’s shares have moved 7.2% on the day to $253.08.
NEW YORK, Feb. 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Danaher Corporation (NYSEDHR) on behalf of long-term stockholders following a class action complaint that was filed against Danaher on July 17, 2023 with a Class Period from April 21, 2022 to April 24, 2023. Our investigation concerns whether the board of directors of Danaher have breached their fiduciary duties to the company.
NEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Danaher Corporation (NYSEDHR) on behalf of long-term stockholders following a class action complaint that was filed against Danaher on July 17, 2023 with a Class Period from April 21, 2022 to April 24, 2023. Our investigation concerns whether the board of directors of Danaher have breached their fiduciary duties to the company.
Danaher raises guidance, sending shares higher, but the move may not last. Resistance is just above current levels and may cap gains until later in the year.
San Diego, CA -- (SBWIRE) -- 11/01/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors and officers of Danaher Corporation.
NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Danaher Corporation (NYSEDHR) between April 21, 2022 and April 24, 2023, both dates inclusive (the “Class Period”), of the important September 15, 2023 lead plaintiff deadline.
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Danaher Corporation (“Danaher” or the “Company”) (NYSEDHR) in the United States District Court for the District of Columbia on behalf of all persons and entities who purchased or otherwise acquired Danaher securities between April 21, 2022 and April 24, 2023, both dates inclusive (the “Class Period”). Investors have until September 15, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
San Diego, CA -- (SBWIRE) -- 09/12/2023 -- The Shareholders Foundation announced that a deadline is coming up on September 15, 2023 in the lawsuit filed for certain investors of Danaher Corporation (NYSEDHR).
WHY: NEW YORK, NY - (NewMediaWire) - September 11, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Danaher Corporation (NYSEDHR) between April 21, 2022 and April 24, 2023, both dates inclusive (the “Class Period”), of the important September 15, 2023 lead plaintiff deadline.
BALA CYNWYD, Pa., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
LOS ANGELES, CA / ACCESSWIRE / September 8, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Danaher Corporation ("Danaher" or "the Company") (NYSEDHR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
BALA CYNWYD, Pa., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
LOS ANGELES, CA / ACCESSWIRE / September 1, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Danaher Corporation ("Danaher" or "the Company") (NYSEDHR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
WHY: NEW YORK, NY - (NewMediaWire) - August 29, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Danaher Corporation (NYSEDHR) between April 21, 2022 and April 24, 2023, both dates inclusive (the “Class Period”), of the important September 15, 2023 lead plaintiff deadline.
